Events & Presentations

LATEST CORPORATE PRESENTATION
DocumentType
May 07, 2018
UPCOMING EVENTS
More events are coming soon.
ARCHIVED EVENTS
DateEvent DetailsRemind Me
May 8, 2018 8:00 AM EDT
Deutsche Bank 43rd Annual Health Care Conference
May 7, 2018 4:30 PM EDT
MacroGenics, Inc. First Quarter 2018 Financial Results Conference Call
Apr 15, 2018 1:00 PM CDT
Presentation of Posters at 2018 AACR Annual Meeting
Feb 27, 2018 4:30 PM EST
MacroGenics, Inc. Fourth Quarter and Full Year 2017 Financial Results Conference Call
Feb 26, 2018 12:00 AM EST
Keystone Symposia (Antibodies as Drugs: Translating Molecules into Treatments): ”Tailoring Cytolytic Activity, Proliferation and Cytokine Release via CD3 Engineering of DART Molecules for Redirected T-cell Killing”
Jan 18, 2018 12:00 AM EST
Presentation of Margetuximab Clinical Data at 2018 ASCO GI Cancers Symposium
Dec 9, 2017 5:30 PM EST
Presentations at 59th Annual ASH Meeting regarding Flotetuzumab (CD123 x CD3 Bispecific DART Protein)
Nov 10, 2017 12:00 AM EST
Data presented at SITC Annual Meeting 2017:
Nov 8, 2017 4:30 PM EST
MacroGenics, Inc. Third Quarter 2017 Financial Results Conference Call
Sep 10, 2017 5:00 AM EDT
Oral Presentation at ESMO 2017
Jun 17, 2017 12:00 AM EDT
MacroGenics Presentation at the Annual European Congress of Rheumatology (EULAR 2016)
Jun 5, 2017 9:00 AM EDT
Trials-in-Progress Poster Presentation at ASCO Annual Meeting 2017
Apr 2, 2017 at 1:00 PM EDT to Apr 4, 2017 at 12:00 AM EDT
Presentation of eight posters at 2017 AACR Annual Meeting
View Additional Information
Jan 20, 2017 12:00 AM EST
Margetuximab TIP Poster Presentation at 2017 ASCO Gastrointestinal Cancers Symposium
Dec 13, 2016 8:30 AM EST
MacroGenics, Inc. R&D Day 2016
Dec 7, 2016 12:00 AM EST
Margetuximab TIP Poster Presentation at San Antonio Breast Cancer Symposium 2016
Jun 10, 2016 5:40 AM EDT
MacroGenics Presentation at the Annual European Congress of Rheumatology (EULAR 2016)
Jun 5, 2016 9:00 AM EDT
Trials-in-Progress Poster Presentation at ASCO Annual Meeting 2016
Apr 17, 2016 at 2:00 PM EDT to Apr 19, 2016 at 12:00 AM EDT
Five Posters Presented at 2016 American Association for Cancer Research (AACR) Annual Meeting
Mar 7, 2016 12:00 AM EST
Preclinical Data Presented at Keystone Symposia's Antibodies as Drugs (X2) Conference: MGD009, a B7-H3 x CD3 Bispecific Dual-Affinity Re-Targeting (DART®) Molecule Directing T Cells to Solid Tumors
Saturday, May 30, 2015 8:00 am CDT
Data Presented at ASCO Annual Meeting 2015: <br> Updated findings of a first-in-human phase 1 study of margetuximab, an Fc-optimized chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors
View Additional Information
Monday, Apr 20, 2015 1:00 pm EDT
Preclincal Data Presented at AACR Annual Meeting 2015:<br> DART&reg; molecules with enhanced DR5 agonistic activity for improved cancer cell cytotoxicity
View Additional Information
Nov 6, 2014 10:00 AM EST
Trials-in-progress posters presented at the 29th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) at National Harbor, MD:
View Additional Information
May 5, 2014 2:30 PM EDT
MacroGenics to Present Pre-Clinical Data on Novel DART Candidate MGD010 for Autoimmune Disorders at IMMUNOLOGY 2014